Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses
ABSTRACT Mass vaccination campaigns are essential to control the ongoing novel severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) pandemic. The Covishield vaccine consists of the replication-deficient simian adenovirus vector ChAdOx1, which contains the full-length structural spike protein...
Published in: | Revista da Sociedade Brasileira de Medicina Tropical |
---|---|
Main Authors: | , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical (SBMT)
2022
|
Subjects: | |
Online Access: | https://doi.org/10.1590/0037-8682-0063-2022 https://doaj.org/article/62aa4c7f05d44b81b6bdd2223bb79faa |
id |
ftdoajarticles:oai:doaj.org/article:62aa4c7f05d44b81b6bdd2223bb79faa |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:62aa4c7f05d44b81b6bdd2223bb79faa 2023-05-15T15:02:39+02:00 Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses Walter de Araujo Eyer-Silva Lidiane Simões de Carvalho Paes Leme 2022-05-01T00:00:00Z https://doi.org/10.1590/0037-8682-0063-2022 https://doaj.org/article/62aa4c7f05d44b81b6bdd2223bb79faa EN eng Sociedade Brasileira de Medicina Tropical (SBMT) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822022000100701&tlng=en https://doaj.org/toc/1678-9849 1678-9849 doi:10.1590/0037-8682-0063-2022 https://doaj.org/article/62aa4c7f05d44b81b6bdd2223bb79faa Revista da Sociedade Brasileira de Medicina Tropical, Vol 55 (2022) Angioedema COVID-19 Covishield Arctic medicine. Tropical medicine RC955-962 article 2022 ftdoajarticles https://doi.org/10.1590/0037-8682-0063-2022 2022-12-30T23:07:10Z ABSTRACT Mass vaccination campaigns are essential to control the ongoing novel severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) pandemic. The Covishield vaccine consists of the replication-deficient simian adenovirus vector ChAdOx1, which contains the full-length structural spike protein of SARS-CoV-2. Occasionally, it can lead to cutaneous reactions that contribute to fear of vaccination, hesitancy, and incomplete vaccination schedules. We report a case of facial angioedema following the first dose of Covishield in a 63-year-old woman with no previous history of allergies or hypersensitivity to drugs or vaccines. No rebound of angioedema was recorded after the second homologous and third heterologous doses. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Revista da Sociedade Brasileira de Medicina Tropical 55 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
Angioedema COVID-19 Covishield Arctic medicine. Tropical medicine RC955-962 |
spellingShingle |
Angioedema COVID-19 Covishield Arctic medicine. Tropical medicine RC955-962 Walter de Araujo Eyer-Silva Lidiane Simões de Carvalho Paes Leme Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses |
topic_facet |
Angioedema COVID-19 Covishield Arctic medicine. Tropical medicine RC955-962 |
description |
ABSTRACT Mass vaccination campaigns are essential to control the ongoing novel severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) pandemic. The Covishield vaccine consists of the replication-deficient simian adenovirus vector ChAdOx1, which contains the full-length structural spike protein of SARS-CoV-2. Occasionally, it can lead to cutaneous reactions that contribute to fear of vaccination, hesitancy, and incomplete vaccination schedules. We report a case of facial angioedema following the first dose of Covishield in a 63-year-old woman with no previous history of allergies or hypersensitivity to drugs or vaccines. No rebound of angioedema was recorded after the second homologous and third heterologous doses. |
format |
Article in Journal/Newspaper |
author |
Walter de Araujo Eyer-Silva Lidiane Simões de Carvalho Paes Leme |
author_facet |
Walter de Araujo Eyer-Silva Lidiane Simões de Carvalho Paes Leme |
author_sort |
Walter de Araujo Eyer-Silva |
title |
Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses |
title_short |
Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses |
title_full |
Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses |
title_fullStr |
Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses |
title_full_unstemmed |
Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses |
title_sort |
facial angioedema after the first dose of covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses |
publisher |
Sociedade Brasileira de Medicina Tropical (SBMT) |
publishDate |
2022 |
url |
https://doi.org/10.1590/0037-8682-0063-2022 https://doaj.org/article/62aa4c7f05d44b81b6bdd2223bb79faa |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
Revista da Sociedade Brasileira de Medicina Tropical, Vol 55 (2022) |
op_relation |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822022000100701&tlng=en https://doaj.org/toc/1678-9849 1678-9849 doi:10.1590/0037-8682-0063-2022 https://doaj.org/article/62aa4c7f05d44b81b6bdd2223bb79faa |
op_doi |
https://doi.org/10.1590/0037-8682-0063-2022 |
container_title |
Revista da Sociedade Brasileira de Medicina Tropical |
container_volume |
55 |
_version_ |
1766334572556976128 |